GlassScriptPhysician profile
Hannah Elise Sinclair
NPI 1437773967
$9,226.18
in general payments reported to CMS, 2019-2025
35 companies · $3,407 in 2025
The $3,407 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.27 · 2022: $900 · 2023: $1,621 · 2024: $3,221 · 2025: $3,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,154 · Education: $94.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,153.50 |
| Education | $94.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,351.70 | 2022-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,183.68 | 2022-2025 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,087.14 | 2022-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Genzyme Corporation | $715.21 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $476.41 | 2023-2025 | Dupixent |
| Grifols USA, LLC | $453.04 | 2022-2025 | Prolastin-C Liquid |
| Amgen INC. | $430.71 | 2022-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $383.20 | 2022-2025 | Uptravi, Opsumit |
| Mallinckrodt Hospital Products INC. | $360.19 | 2023-2025 | Acthar |
| Insmed, INC. | $317.95 | 2023-2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $240.70 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Nevro Corp. | $235.71 | 2021-2022 | |
| United Therapeutics Corporation | $235.56 | 2024-2025 | Tyvaso, Tyvaso |
| Mylan Specialty L.P. | $227.11 | 2022-2024 | Yupelri |
| Verona Pharma, INC. | $220.39 | 2025 | Ohtuvayre |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $180.78 | 2022-2025 | Aralast, Glassia |
| Inspire Medical Systems, INC. | $179.79 | 2024-2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $150.04 | 2023-2025 | Nuzyra |
| Harmony Biosciences LLC | $129.03 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $94.95 | 2023 | |
| Viatris Specialty LLC | $93.71 | 2025 | Yupelri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.70 | 2022 | |
| Genentech USA, INC. | $60.91 | 2022-2024 | Xolair |
| Pulmonx Corporation | $51.93 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Electromed, INC. | $49.68 | 2024 | Smartvest |
| Avadel Cns Pharmaceuticals, LLC | $32.45 | 2025 | Lumryz |
| Inogen, INC. | $31.92 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Uswm, LLC | $31.30 | 2021 | |
| Axsome Therapeutics, INC. | $30.20 | 2025 | Sunosi |
| Zoll Respicardia, INC. | $27.80 | 2025 | Remede System |
| La Jolla Pharmaceutical Company | $22.02 | 2024 | Giapreza |
| Intuitive Surgical, INC. | $19.76 | 2025 | |
| Hikma Pharmaceuticals USA | $16.88 | 2022 | |
| Alkermes, INC. | $14.42 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Sinclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.